Comprehensive pulmonary rehabilitation for post-tuberculosis lung disease: a narrative review
Abstract
Around 155 million people worldwide are tuberculosis (TB) survivors, many of whom experience post-tuberculosis lung disease (PTLD), characterized by structural lung abnormalities, impaired pulmonary function, persistent respiratory symptoms, reduced exercise capacity, and poorer quality of life. The burden of PTLD is particularly important in low- and middle-income countries (LMICs), where access to pulmonary rehabilitation (PR) and long-term post-TB care remains limited. This narrative review synthesizes current evidence on comprehensive PR for PTLD and considers its implementation across diverse healthcare settings. Available studies suggest that PR can improve exercise capacity, respiratory symptoms, functional status, and health-related quality of life in individuals with post-TB pulmonary impairment, although PTLD-specific evidence remains limited and heterogeneous. Comprehensive rehabilitation extends beyond exercise training to include breathing and airway-clearance strategies, nutritional support, psychological and psychosocial care, patient education, and tele-rehabilitation. Where direct PTLD-specific evidence is limited, established evidence and principles from rehabilitation in other chronic respiratory diseases may inform the adaptation of these components to post-TB care. Key implementation challenges in resource-constrained settings include limited rehabilitation infrastructure, workforce and financial constraints, geographical barriers, and poor integration…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.